News: HPV vaccine's cost effectiveness in question

Article

Optimizing the cost effectiveness of HPV vaccine depends on several factors.

Optimizing the cost effectiveness of human papillomavirus (HPV) vaccination depends on several factors: the duration of vaccine immunity, achieving universal coverage in pre-adolescent girls, targeting catch-up vaccinations among young women, and revising screening guidelines, according to a report published in the Aug. 21 issue of the New England Journal of Medicine.

Jane J. Kim, PhD, of the Harvard School of Public Health in Boston, and a colleague used computer models of HPV-16 and HPV-18 transmission and cervical carcinogenesis to compare the health and economic outcomes of vaccinating several age groups: 12-year-old girls, and women at ages 18, 21, and 26 as part of a catch-up program.

The researchers found that the cost-effectiveness ratio per quality-adjusted life-year gained was considerably lower for vaccinating 12-year-old girls ($43,600) compared to vaccinating women at ages 18, 21, and 26 ($97,300, $120,400, and $152,700, respectively). But these figures were based on the assumption that vaccination provides lifelong immunity. In the event that immunity declines after 10 years, the cost effectiveness of vaccinating 12-year-old girls would increase to more than $140,000, and catch-up strategies would be less cost effective than screening alone, according to the report.

Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359:821-832.

Recent Videos
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.